Cachet Pharmaceutical Co., Ltd.
Simbolis: 002462.SZ
SHZ
12.28
CNYRinkos kaina šiandien
14.3690
P/E santykis
0.7993
PEG koeficientas
3.58B
MRK kapitalizacija
- 0.02%
DIV pajamingumas
Cachet Pharmaceutical Co., Ltd. (002462-SZ) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 10532.55 | 2885.6 | 2183.7 | 2338.4 | |||||||||||||||||
balance-sheet.row.short-term-investments | 0.59 | 0.1 | 0.2 | 0.2 | |||||||||||||||||
balance-sheet.row.net-receivables | 38852.37 | 9187.4 | 9948 | 8640.8 | |||||||||||||||||
balance-sheet.row.inventory | 10431.64 | 2561.7 | 2692.3 | 2185.4 | |||||||||||||||||
balance-sheet.row.other-current-assets | 630.57 | 156.7 | 171.6 | 120.8 | |||||||||||||||||
balance-sheet.row.total-current-assets | 60447.13 | 15630.5 | 14995.6 | 13285.3 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 2752.52 | 679.7 | 735.9 | 850.3 | |||||||||||||||||
balance-sheet.row.goodwill | 1983.55 | 475.9 | 515.9 | 562.4 | |||||||||||||||||
balance-sheet.row.intangible-assets | 142.71 | 35.6 | 35.8 | 36.6 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 2126.27 | 511.4 | 551.7 | 599 | |||||||||||||||||
balance-sheet.row.long-term-investments | 7.78 | 1.7 | 2.3 | 2.3 | |||||||||||||||||
balance-sheet.row.tax-assets | 374.33 | 93 | 68.1 | 52.6 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 789.85 | 204.4 | 203 | 148.2 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 6050.75 | 1490.3 | 1561 | 1652.3 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 66497.88 | 17120.9 | 16556.6 | 14937.5 | |||||||||||||||||
balance-sheet.row.account-payables | 23067.09 | 5858.1 | 5319.5 | 4442.4 | |||||||||||||||||
balance-sheet.row.short-term-debt | 14121.28 | 3842.7 | 4068 | 3774.5 | |||||||||||||||||
balance-sheet.row.tax-payables | 394.27 | 115.5 | 96.8 | 99.8 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 781.08 | 175.9 | 208.8 | 229.2 | |||||||||||||||||
Deferred Revenue Non Current | -4.3 | -4.3 | 0 | 0 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 30.66 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 130.84 | 53 | 732.8 | 34 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 811.74 | 180.2 | 220 | 259.2 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 781.08 | 175.9 | 208.8 | 229.2 | |||||||||||||||||
balance-sheet.row.total-liab | 42070.44 | 11029.3 | 10635 | 9281 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 1166.83 | 291.7 | 291.7 | 291.7 | |||||||||||||||||
balance-sheet.row.retained-earnings | 9684.4 | 2430.6 | 2268.1 | 2079.1 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 3516.49 | 0 | 240 | 237.6 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 2556.4 | 1518.2 | 1278.2 | 1278.2 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 16924.12 | 4240.5 | 4078 | 3886.5 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 66497.88 | 17120.9 | 16556.6 | 14937.5 | |||||||||||||||||
balance-sheet.row.minority-interest | 7503.32 | 1851 | 1843.6 | 1770 | |||||||||||||||||
balance-sheet.row.total-equity | 24427.44 | 6091.5 | 5921.6 | 5656.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 66497.88 | - | - | - | |||||||||||||||||
Total Investments | 8.37 | 1.7 | 2.4 | 2.5 | |||||||||||||||||
balance-sheet.row.total-debt | 14902.36 | 4018.7 | 4276.8 | 4003.8 | |||||||||||||||||
balance-sheet.row.net-debt | 4370.4 | 1133.2 | 2093.2 | 1665.6 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 257.86 | 468.3 | 601.9 | 590.9 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 168.35 | 226.7 | 201.1 | 175.9 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -34.3 | -3.5 | 0.3 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 34.3 | 3.5 | -0.3 | ||||||||||||||||
cash-flows.row.change-in-working-capital | -528.8 | -1216.3 | -133.8 | -47.7 | ||||||||||||||||
cash-flows.row.account-receivables | -601.58 | -2437.7 | -655.1 | -699 | ||||||||||||||||
cash-flows.row.inventory | 72.78 | -510.7 | -179.8 | 183.5 | ||||||||||||||||
cash-flows.row.account-payables | 0 | 1766.3 | 704.7 | 467.5 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | -34.3 | -3.5 | 0.3 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 1271.58 | 357.8 | 243.9 | 395.7 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 1168.99 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -197.7 | -188.5 | -247 | -258 | ||||||||||||||||
cash-flows.row.acquisitions-net | 50.76 | -1.6 | 59.2 | 1.4 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 3.92 | 0 | -16.2 | -42 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | -25.33 | 10.9 | 2.3 | 1 | ||||||||||||||||
cash-flows.row.other-investing-activites | 31.44 | 3.8 | -55.5 | 4.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -168.68 | -175.4 | -257.1 | -293.5 | ||||||||||||||||
cash-flows.row.debt-repayment | -3431.74 | -4619.6 | -3975.2 | -4948.4 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | -207.44 | -282.3 | -242.7 | -289.1 | ||||||||||||||||
cash-flows.row.other-financing-activites | 1938.41 | 4739.1 | 3884.8 | 4864 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -753.17 | -162.8 | -333.1 | -373.5 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | -0.7 | -0.4 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 247.14 | -501.7 | 322.2 | 447.4 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 8914.64 | 1699.3 | 2201 | 1878.8 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 8667.5 | 2201 | 1878.8 | 1431.4 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 1168.99 | -163.4 | 913.1 | 1114.9 | ||||||||||||||||
cash-flows.row.capital-expenditure | -197.7 | -188.5 | -247 | -258 | ||||||||||||||||
cash-flows.row.free-cash-flow | 971.3 | -352 | 666.2 | 856.9 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 30683.14 | 29996.2 | 26219.8 | 25625.6 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 28755.67 | 28018.5 | 24112.2 | 23484.9 | |||||||||||||||||
income-statement-row.row.gross-profit | 1927.46 | 1977.7 | 2107.6 | 2140.8 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 61.72 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 678.23 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -0.53 | -12 | 263.7 | 234.2 | |||||||||||||||||
income-statement-row.row.operating-expenses | 1023.97 | 1072.1 | 1162 | 1103.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 29779.65 | 29090.6 | 25274.3 | 24588.6 | |||||||||||||||||
income-statement-row.row.interest-income | 189.45 | 31.1 | -22.4 | 17.1 | |||||||||||||||||
income-statement-row.row.interest-expense | 73.91 | 155.4 | 175.3 | 164.2 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 678.23 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -217.24 | -350.4 | -292 | -6.8 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -0.53 | -12 | 263.7 | 234.2 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -217.24 | -350.4 | -292 | -6.8 | |||||||||||||||||
income-statement-row.row.interest-expense | 73.91 | 155.4 | 175.3 | 164.2 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 281.99 | 202.1 | 226.7 | 408.3 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 904.8 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 573.55 | 556.4 | 936.9 | 830.8 | |||||||||||||||||
income-statement-row.row.income-before-tax | 583.96 | 555.3 | 644.9 | 824 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 187.67 | 178.7 | 176.6 | 222.1 | |||||||||||||||||
income-statement-row.row.net-income | 257.86 | 250.1 | 468.3 | 601.9 |
Dažnai užduodami klausimai
Kas yra Cachet Pharmaceutical Co., Ltd. (002462.SZ) bendras turtas?
Cachet Pharmaceutical Co., Ltd. (002462.SZ) bendras turtas yra 17120851592.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra 15651563096.000.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.063.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 3.329.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.008.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.019.
Kas yra Cachet Pharmaceutical Co., Ltd. (002462.SZ) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 250060041.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 4018688843.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 1072054997.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 2853572169.000.